Q4 2017 Holdings
Filed 2018-02-14 | 74 holdings | $51.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $21.3M | 531,000 | 41.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $20.4M | 323,000 | 39.6% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $4.4M | 900,000 | 8.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.7M | 90,000 | 5.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.3M | 92,500 | 4.4% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $109.1K | 6,750,000 | 0.2% |
| Assembly Biosciences Inc | COM | 045396108 | $49.2K | 1,087,104 | 0.1% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $38.1K | 250,000 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $31.1K | 3,892,000 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $29.7K | 350,000 | 0.1% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $21.5K | 3,295,111 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $17.8K | 4,915,000 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $17.7K | 1,915,654 | 0.0% |
| Iridex Corp(IRIX) | COM | 462684101 | $15.2K | 2,000,000 | 0.0% |
| Chembio Diagnostics Inc(CEMIUSD) | COM NEW | 163572209 | $14.1K | 1,721,299 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $14.0K | 2,724,283 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $12.0K | 300,000 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $8.8K | 943,906 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $6.1K | 450,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $5.9K | 52,900 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $5.2K | 420,000 | 0.0% |
| Ishares TR(FXI)Put | CHINA LG-CAP ETF | 464287184 | $4.6K | 100,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $4.3K | 311,169 | 0.0% |
| Seattle Genetics IncCall | COM | 812578102 | $4.3K | 80,000 | 0.0% |
| CAS MED SYS Inc | COM PAR | 124769209 | $4.0K | 5,160,000 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $3.5K | 580,000 | 0.0% |
| Global Blood Therapeutics inCall | COM | 37890U108 | $3.1K | 80,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.8K | 155,000 | 0.0% |
| Rockwell MED IncPut | COM | 774374102 | $2.6K | 440,000 | 0.0% |
| Loxo Oncology IncPut | COM | 548862101 | $2.5K | 30,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $2.5K | 250,000 | 0.0% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $2.4K | 80,000 | 0.0% |
| Agios Pharmaceuticals Inc(AGIO)Put | COM | 00847X104 | $2.3K | 40,000 | 0.0% |
| Viveve MED Inc | COM NEW | 92852W204 | $2.2K | 433,419 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $2.2K | 36,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $2.1K | 46,000 | 0.0% |
| Valeant Pharmaceuticals IntlCall | COM | 91911K102 | $2.1K | 100,000 | 0.0% |
| Editas Medicine Inc(EDIT)Call | COM | 28106W103 | $2.0K | 64,000 | 0.0% |
| Orasure Technologies Inc(OSUR)Put | COM | 68554V108 | $1.9K | 100,000 | 0.0% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $1.9K | 80,000 | 0.0% |
| Nektar Therapeutics(NKTREUR)Put | COM | 640268108 | $1.8K | 30,000 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG)Put | COM | 00163U106 | $1.8K | 132,500 | 0.0% |
| Juno Therapeutics IncCall | COM | 48205A109 | $1.7K | 37,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA)Call | COM | 45826J105 | $1.7K | 86,000 | 0.0% |
| Stemline Therapeutics IncCall | COM | 85858C107 | $1.6K | 105,000 | 0.0% |
| Seattle Genetics IncPut | COM | 812578102 | $1.6K | 30,000 | 0.0% |
| Exelixis Inc(EXEL)Call | COM | 30161Q104 | $1.5K | 50,000 | 0.0% |
| Teladoc Inc(TDOC)Put | COM | 87918A105 | $1.4K | 40,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $1.4K | 152,300 | 0.0% |
| Alimera Sciences Inc | COM | 016259103 | $1.3K | 974,318 | 0.0% |